%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Bell, D.
%A Brown, G. W.
%A Oyibo, W. A.
%A Ouedraogo, S.
%A Tacheva, B.
%A Barbaud, E.
%A Kalk, A.
%A Ridde, Valéry
%A Paul, E.
%T COVAX - Time to reconsider the strategy and its target
%D 2023
%L fdi:010088923
%G ENG
%J Health Policy Open
%M ISI:001135964800001
%P 100096 [6 ]
%R 10.1016/j.hpopen.2023.100096
%U https://www.documentation.ird.fr/hor/fdi:010088923
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-02/010088923.pdf
%V 4
%W Horizon (IRD)
%X COVAX, the international initiative supporting COVID-19 vaccination campaigns globally, is budgeted to be the costliest public health initiative in low- and middle-income countries, with over 16 billion US dollars already committed. While some claim that the target of vaccinating 70% of people worldwide is justified on equity grounds, we argue that this rationale is wrong for two reasons. First, mass COVID-19 vaccination campaigns do not meet standard public health requirements for clear expected benefit, based on costs, disease burden and intervention effectiveness. Second, it constitutes a diversion of resources from more cost-effective and impactful public health programmes, thus reducing health equity. We conclude that the COVAX initiative warrants urgent review.
%$ 056 ; 052